[HTML][HTML] TRPA1-Related Diseases and Applications of Nanotherapy

D Yang - International Journal of Molecular Sciences, 2024 - mdpi.com
Transient receptor potential (TRP) channels, first identified in Drosophila in 1969, are
multifunctional ion channels expressed in various cell types. Structurally, TRP channels …

Exploring the complex and multifaceted interplay between melanoma cells and the tumor microenvironment

M Kuras - International Journal of Molecular Sciences, 2023 - mdpi.com
Malignant melanoma is a very aggressive skin cancer, characterized by a heterogeneous
nature and high metastatic potential. The incidence of melanoma is continuously increasing …

[HTML][HTML] Classification of the tumor immune microenvironment and associations with outcomes in patients with metastatic melanoma treated with immunotherapies

NA Adegoke, TN Gide, Y Mao, C Quek… - … for ImmunoTherapy of …, 2023 - ncbi.nlm.nih.gov
Background Tumor microenvironment (TME) characteristics are potential biomarkers of
response to immune checkpoint inhibitors in metastatic melanoma. This study developed a …

FcγRIIB is an immune checkpoint limiting the activity of treg-targeting antibodies in the tumor microenvironment

DA Knorr, L Blanchard, RS Leidner, SM Jensen… - Cancer immunology …, 2024 - AACR
Preclinical murine data indicate that fragment crystallizable (Fc)-dependent depletion of
intratumoral regulatory T cells (Treg) is a major mechanism of action of anti–CTLA-4 …

Unveiling efferocytosis-related signatures through the integration of single-cell analysis and machine learning: a predictive framework for prognosis and …

T Liu, C Li, J Zhang, H Hu, C Li - Frontiers in Immunology, 2023 - frontiersin.org
Background Hepatocellular carcinoma (HCC) represents a prominent gastrointestinal
malignancy with a grim clinical outlook. In this regard, the discovery of novel early …

Genomic and Epigenomic Biomarkers of Immune Checkpoint Immunotherapy Response in Melanoma: Current and Future Perspectives

SM Hossain, C Carpenter, MR Eccles - International journal of molecular …, 2024 - mdpi.com
Immune checkpoint inhibitors (ICIs) demonstrate durable responses, long-term survival
benefits, and improved outcomes in cancer patients compared to chemotherapy. However …

Botensilimab, an Fc-Enhanced Anti–CTLA-4 Antibody, Is Effective against Tumors Poorly Responsive to Conventional Immunotherapy

D Chand, DA Savitsky, S Krishnan, G Mednick… - Cancer …, 2024 - aacrjournals.org
Conventional immune checkpoint inhibitors (ICI) targeting cytotoxic T-lymphocyte antigen 4
(CTLA-4) elicit durable survival but primarily in patients with immune-inflamed tumors …

Antigen presenting cells in cancer immunity and mediation of immune checkpoint blockade

C Wang, L Chen, D Fu, W Liu, A Puri, M Kellis… - Clinical & Experimental …, 2024 - Springer
Antigen-presenting cells (APCs) are pivotal mediators of immune responses. Their role has
increasingly been spotlighted in the realm of cancer immunology, particularly as our …

Tissue-Based Profiling Techniques to Achieve Precision Medicine in Cancer: Opportunities and Challenges in Melanoma

TN Gide, Y Mao, RA Scolyer, GV Long… - Clinical Cancer …, 2024 - aacrjournals.org
Immunotherapies targeting the programmed cell death 1 (PD-1) and cytotoxic T-lymphocyte
antigen 4 (CTLA-4) checkpoint receptors have revolutionized the treatment of metastatic …

[HTML][HTML] Targeting tumor-associated macrophages: novel insights into immunotherapy of skin cancer

J Liu, J Lu, L Wu, T Zhang, J Wu, L Li, Z Tai… - Journal of Advanced …, 2025 - Elsevier
Background The incidence of skin cancer is currently increasing, and conventional treatment
options inadequately address the demands of disease management. Fortunately, the recent …